SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Bouchard Mercier, Annie ^a,b   Rudkowska, Iwona ^b   Lemieux, Simone ^a   Couture, Patrick ^a,b   Pérusse, Louis ^a   Vohl, Marie Claude ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Fish oil supplementation; Insulin sensitivity; Inter individual variability; Polymorphisms; SREBF1 gene

Indexed keywords

CHOLESTEROL; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; GLUCOSE BLOOD LEVEL; PHOSPHOLIPID; SREBF1 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET SUPPLEMENTATION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INSULIN SENSITIVITY; MALE; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; ERYTHROCYTE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; FISH OILS; GENE EXPRESSION; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHOSPHOLIPIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; YOUNG ADULT;

EID: 84907976580     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-152     Document Type: Article

References (65)

1. SREBP transcription factors: master regulators of lipid homeostasis. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F, Biochimie 2004 86 839 848 10.1016/j.biochi.2004.09.018 15589694
2. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS, J Clin Invest 1997 99 838 845 10.1172/JCI119247 9062340
3. Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction. Shimano H, Amemiya-Kudo M, Takahashi A, Kato T, Ishikawa M, Yamada N, Diabetes Obes Metab 2007 9 Suppl 2 133 139 17919187
4. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Takahashi A, Motomura K, Kato T, Yoshikawa T, Nakagawa Y, Yahagi N, Sone H, Suzuki H, Toyoshima H, Yamada N, Shimano H, Diabetes 2005 54 492 499 10.2337/diabetes.54.2.492 15677507
5. Exendin-4 inhibits glucolipotoxic ER stress in pancreatic beta cells via regulation of SREBP1c and C/EBPbeta transcription factors. Oh YS, Lee YJ, Kang Y, Han J, Lim OK, Jun HS, J Endocrinol 2013 216 343 352 10.1530/JOE-12-0311 23257266
6. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Tomita S, Sekiya M, Hasty A, Nakagawa Y, Sone H, Toyoshima H, Ishibashi S, Osuga J, Yamada N, Diabetes 2004 53 560 569 10.2337/diabetes.53.3.560 14988238
7. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM, Cell 2005 120 261 273 10.1016/j.cell.2004.11.043 15680331
8. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H, Hepatology 2003 38 1529 1539 10.1016/j.hep.2003.09.028 14647064
9. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS, J Biol Chem 2001 276 4365 4372 10.1074/jbc.M007273200 11085986
10. Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques. Bremer AA, Stanhope KL, Graham JL, Cummings BP, Ampah SB, Saville BR, Havel PJ, J Nutr 2013 144 5 11 24108131
11. Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet. Lanza IR, Blachnio-Zabielska A, Johnson ML, Schimke JM, Jakaitis DR, Lebrasseur NK, Jensen MD, Sreekumaran Nair K, Zabielski P, Am J Physiol Endocrinol Metab 2013 304 1391 E1403 10.1152/ajpendo.00584.2012 23632634
12. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J, FASEB J 2009 23 1946 1957 10.1096/fj.08-125674 19211925
13. Peroxisome proliferator-activated receptors (PPARs)-independent functions of fish oil on glucose and lipid metabolism in diet-induced obese mice. Wakutsu M, Tsunoda N, Shiba S, Muraki E, Kasono K, Lipids Health Dis 2010 9 101 10.1186/1476-511X-9-101 20846400
14. Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice. Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T, Biochem Pharmacol 2010 80 1601 1612 10.1016/j.bcp.2010.07.031 20691165
15. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Kato T, Shimano H, Yamamoto T, Ishikawa M, Kumadaki S, Matsuzaka T, Nakagawa Y, Yahagi N, Nakakuki M, Hasty AH, Takeuchi Y, Kobayashi K, Takahashi A, Yatoh S, Suzuki H, Sone H, Yamada N, Diabetes 2008 57 2382 2392 10.2337/db06-1806 18458149
16. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjögren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC, Hum Mol Genet 2003 12 1865 1873 10.1093/hmg/ddg195 12874106
17. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Eberle D, Clement K, Meyre D, Sahbatou M, Vaxillaire M, Le GA, Ferré P, Basdevant A, Froquel P, Foufelle F, Diabetes 2004 53 2153 2157 10.2337/diabetes.53.8.2153 15277400
18. Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Laudes M, Barroso I, Luan J, Soos MA, Yeo G, Meirhaeghe A, Logie L, Vidal-Puig A, Schafer AJ, Wareham NJ, O'Rahilly S, Diabetes 2004 53 842 846 10.2337/diabetes.53.3.842 14988272
19. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, Lanktree MB, Tare A, Castillo BA, Li YR, Johnson T, Bruinenberg M, Gilbert-Diamond D, Rajagopalan R, Voight BF, Balasubramanyam A, Barnard J, Bauer F, Baumert J, Bhangale T, Böhm BO, Braund PS, Burton PR, Chandrupatla HR, Clarke R, Cooper-DeHoff RM, Crook ED, Davey-Smith G, Day IN, de Boer A, et al. Am J Hum Genet 2012 90 410 425 10.1016/j.ajhg.2011.12.022 22325160
20. Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Grarup N, Stender-Petersen KL, Andersson EA, Jorgensen T, Borch-Johnsen K, Sandbaek A, Lauritzen T, Schmitz O, Hansen T, Pedersen O, Diabetes 2008 57 1136 1142 10.2337/db07-1534 18192539
21. The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. Felder TK, Oberkofler H, Weitgasser R, Mackevics V, Krempler F, Paulweber B, Patsch W, Int J Obes (Lond) 2007 31 1099 1103 10.1038/sj.ijo.0803505 17160088
22. Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population. Liu JX, Liu J, Li PQ, Xie XD, Guo Q, Tian LM, Ma XQ, Zhang JP, Liu J, Gao JY, Diabetes Res Clin Pract 2008 82 42 47 10.1016/j.diabres.2008.06.017 18692268
23. Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes. Ogawa S, Abe T, Nako K, Okamura M, Senda M, Sakamoto T, Ito S, DIMS Study Group, Tohoku J Exp Med 2013 231 63 74 10.1620/tjem.231.63 24067797
24. The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. Lopez-Huertas E, Br J Nutr 2012 107 Suppl 2 185 S194 22591892
25. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, Paniaqua JA, Golabek-Leszczynska I, Defoort C, Williams CM, Karsltröm B, Vessby B, Dembinska-Kiec A, Lopez-Miranda J, Blaak EE, Drevon CA, Gibney MJ, Lovegrove JA, Roche HM, Int J Obes (Lond) 2011 35 800 809 10.1038/ijo.2010.209 20938439
26. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV, N Engl J Med 1993 328 238 244 10.1056/NEJM199301283280404 8418404
27. Role of dietary n-3 polyunsaturated fatty acids in type 2 diabetes: a review of epidemiological and clinical studies. Jafari T, Fallah AA, Azadbakht L, Maturitas 2013 74 303 308 10.1016/j.maturitas.2013.01.008 23384976
28. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ, Am J Clin Nutr 2000 71 1085 1094 10799369
29. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ, Am J Clin Nutr 2002 76 1007 1015 12399272
30. Polymorphisms in Fatty Acid Desaturase (FADS) gene cluster: effects on glycemic controls following an omega-3 Polyunsaturated Fatty Acids (PUFA) supplementation. Cormier H, Rudkowska I, Thifault E, Lemieux S, Couture P, Vohl MC, Genes (Basel) 2013 4 485 498 10.3390/genes4030485 24705214
31. Polymorphisms, de novo lipogenesis, and plasma triglyceride response following fish oil supplementation. Bouchard-Mercier A, Rudkowska I, Lemieux S, Couture P, Vohl MC, J Lipid Res 2013 54 2866 2873 10.1194/jlr.M041590 23886516
32. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S, Nutr J 2004 3 13 10.1186/1475-2891-3-13 15363100
33. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. McNamara JR, Schaefer EJ, Clin Chim Acta 1987 166 1 8 10.1016/0009-8981(87)90188-4 3608193
34. [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins]. Burstein M, Samaille J, Clin Chim Acta 1960 5 609 10.1016/0009-8981(60)90075-9 13806309
35. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Albers JJ, Warnick GR, Wiebe D, King P, Steiner P, Smith L, Breckenridge C, Chow A, Kuba K, Weidman S, Arnett H, Wood P, Shlagenhaft A, Clin Chem 1978 24 853 856 207461
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
37. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. Desbuquois B, Aurbach GD, J Clin Endocrinol Metab 1971 33 732 738 10.1210/jcem-33-5-732 5166455
38. [Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method]. Richterich R, Dauwalder H, Schweiz Med Wochenschr 1971 101 615 618 5576952
39. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ, J Clin Endocrinol Metab 2000 85 2402 2410 10.1210/jcem.85.7.6661 10902785
40. HOMA or QUICKI: is it useful to test the reproducibility of formulas? Antuna-Puente B, Faraj M, Karelis AD, Garrel D, Prud'homme D, Rabasa-Lhoret R, Bastard JP, Diabetes Metab 2008 34 294 296 10.1016/j.diabet.2008.02.001 18468934
41. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Muniyappa R, Lee S, Chen H, Quon MJ, Am J Physiol Endocrinol Metab 2008 294 15 E26 17957034
42. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Livak KJ, Genet Anal 1999 14 143 149 10.1016/S1050-3862(98)00019-9 10084106
43. Association between Polymorphisms in the Fatty Acid Desaturase Gene Cluster and the Plasma Triacylglycerol Response to an n-3 PUFA Supplementation. Cormier H, Rudkowska I, Paradis AM, Thifault E, Garneau V, Lemieux S, Couture P, Vohl MC, Nutrients 2012 4 1026 1041 10.3390/nu4081026 23016130
44. Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic Caucasian population. Rudkowska I, Paradis AM, Thifault E, Julien P, Tchernof A, Couture P, Lemieux S, Barbier O, Vohl MC, J Nutr Biochem 2013 24 54 61 10.1016/j.jnutbio.2012.01.016 22748805
45. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Shaikh NA, Downar E, Circ Res 1981 49 316 325 10.1161/01.RES.49.2.316 7249269
46. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Kroger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D, Am J Clin Nutr 2009 90 184 192 10.3945/ajcn.2008.26987 19474137
47. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA, J Lab Clin Med 2006 147 126 132 10.1016/j.lab.2005.10.005 16503242
48. Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. Rudkowska I, Raymond C, Ponton A, Jacques H, Lavigne C, Holub BJ, Marette A, Vohl MC, OMICS 2011 15 1 7 10.1089/omi.2010.0073 21194298
49. Associations between dietary patterns and obesity phenotypes. Paradis AM, Godin G, Perusse L, Vohl MC, Int J Obes (Lond) 2009 33 1419 1426 10.1038/ijo.2009.179 19736556
50. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Gao X, Starmer J, Martin ER, Genet Epidemiol 2008 32 361 369 10.1002/gepi.20310 18271029
51. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis AM, Garneau V, Ouellette C, Lemieux S, Couture P, Vohl MC, J Nutrigenet Nutrigenomics 2013 6 73 82 10.1159/000350744 23689286
52. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel, Circulation 2002 106 3143 3421 12485966
53. Canadian Diabetes Association, Screening for and Diagnosing Diabetes [ http://guidelines.diabetes.ca/ScreeningAndDiagnosis/Screening ]
54. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L, J Clin Endocrinol Metab 2002 87 144 147 10.1210/jcem.87.1.8292 11788638
55. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H, Toyoshima H, Fukamizu A, Yamada N, Nat Cell Biol 2004 6 351 357 10.1038/ncb1111 15048126
56. Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, Daniel KW, Collins S, J Biol Chem 2002 277 42639 42644 10.1074/jbc.M208645200 12205102
57. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB, Diabetes 1999 48 1482 1486 10.2337/diabetes.48.7.1482 10389858
58. Omega-3 polyunsaturated fatty acid regulation of gene expression. Price PT, Nelson CM, Clarke SD, Curr Opin Lipidol 2000 11 3 7 10.1097/00041433-200002000-00002 10750688
59. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D, Br J Nutr 2012 107 Suppl 2 214 S227 22591895
60. Fish oil and glycemic control in diabetes. A meta-analysis. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE, Diabetes Care 1998 21 494 500 10.2337/diacare.21.4.494 9571330
61. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Puhakainen I, Ahola I, Yki-Jarvinen H, Am J Clin Nutr 1995 61 121 126 7825523
62. Fish oil positively regulates anabolic signalling alongside an increase in whole-body gluconeogenesis in ageing skeletal muscle. Kamolrat T, Gray SR, Thivierge MC, Eur J Nutr 2013 52 647 657 10.1007/s00394-012-0368-7 22581256
63. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Berger A, Mutch DM, German JB, Roberts MA, Lipids Health Dis 2002 1 2 10.1186/1476-511X-1-2 12617750
64. Associations of the SREBP-1c gene polymorphism with gender-specific changes in serum lipids induced by a high-carbohydrate diet in healthy Chinese youth. Zhang Z, Gong RR, Du J, Xiao LY, Duan W, Zhou XD, Fang DZ, Appl Physiol Nutr Metab 2011 36 226 232 10.1139/h11-005 21609284
65. Single nucleotide polymorphism (-468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis [corrected]. Nagata R, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Maegawa H, Kashiwagi A, J Biol Chem 2004 279 29031 29042 10.1074/jbc.M309449200 15123654